These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5150030)

  • 1. Trial of high dosages of dapsone in the treatment of tuberculoid leprosy.
    Prasad BN
    Lepr Rev; 1971 Jun; 42(2):118-20. PubMed ID: 5150030
    [No Abstract]   [Full Text] [Related]  

  • 2. Multicentre controlled comparative trial of clofazimine and dapsone in low dosages.
    Ahrens TF; Pettit JH; Ridley DS; Glaus L
    Lepr Rev; 1975 Dec; 46(4):287-96. PubMed ID: 1107728
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of low and conventional dosages of dapsone in the treatment of lepromatous leprosy.
    Iyer CG; Balakrishnan S; Ramu G
    Lepr India; 1977 Jul; 49(3):372-86. PubMed ID: 592740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of leprosy.
    Ramanujam K
    J Indian Med Assoc; 1973 Nov; 61(9):401-2. PubMed ID: 4791935
    [No Abstract]   [Full Text] [Related]  

  • 5. A report on a controlled clinical trial with conventional and one third conventional dose of dapsone administered orally once a week in lepromatous patients.
    Ramanujam K; Iyer CG; Ramu G
    Lepr Rev; 1975 Jun; 46(2 Suppl):93-7. PubMed ID: 1100971
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient compliance with dapsone administration in leprosy.
    Huikeshoven H
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):228-58. PubMed ID: 7024150
    [No Abstract]   [Full Text] [Related]  

  • 7. Dapsone induced psychosis.
    Balkrishna ; Bhatia MS
    J Indian Med Assoc; 1989 May; 87(5):120-1. PubMed ID: 2600436
    [No Abstract]   [Full Text] [Related]  

  • 8. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of DDS therapy on the acetylcholine sweat function test in fifty cases of tuberculoid and maculoanesthetic leprosy.
    Yawalkar SJ; Sanjana HB
    Int J Lepr Other Mycobact Dis; 1974; 42(1):55-7. PubMed ID: 4472091
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs for leprosy.
    Rees RJ
    Trop Doct; 1973 Apr; 3(2):92-5. PubMed ID: 4691437
    [No Abstract]   [Full Text] [Related]  

  • 11. Fatal reaction to dapsone during treatment of leprosy.
    Frey HM; Gershon AA; Borkowsky W; Bullock WE
    Ann Intern Med; 1981 Jun; 94(6):777-9. PubMed ID: 7235421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Low doses of dapsone in the treatment of leprosy.
    Jopling WH
    Int J Lepr Other Mycobact Dis; 1972; 40(4):419. PubMed ID: 4677498
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 14. Study of multidrug therapy in paucibacillary leprosy.
    Kar PK; Sohi AS
    J Indian Med Assoc; 1989 Feb; 87(2):34-6. PubMed ID: 2674283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of dapsone self-administration by leprosy patients in the Rangoon area.
    Gyi KM; Lwin MM; Myaing YY; Oo KM; Shwe T
    Lepr Rev; 1978 Dec; 49(4):283-6. PubMed ID: 153997
    [No Abstract]   [Full Text] [Related]  

  • 16. Borderline leprosy reactions and dapsone.
    Lancet; 1977 Jan; 1(8001):44-5. PubMed ID: 63682
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of MDT implementation in the Tanzania National TB-Leprosy Programme.
    Chum HJ
    Lepr Rev; 1986; 57 Suppl 3():63-6. PubMed ID: 3573963
    [No Abstract]   [Full Text] [Related]  

  • 18. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations into the haemolytic effects of dapsone therapy in leprosy patients.
    Balakrishnan S; Karthikeyan S; Ramu G
    Indian J Lepr; 1989 Jan; 61(1):10-6. PubMed ID: 2703739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six cases of dapsone-resistant tuberculoid leprosy.
    Pearson JM; Kiran KU; Stanley JN
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):534-5. PubMed ID: 6399070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.